Percutaneous coronary intervention for left main coronary artery disease

References

• Conley MJ, Ely RL, Kisslo J, Lee KL, McNeer JF, Rosati RA. The prognostic spectrum of left main stenosis. Circulation57, 947–952 (1978).
   PubMed Web of Science ®Google Scholar
• Lim JS, Proudfit WL, Sones FM Jr. Left main coronary arterial obstruction: Long-term follow-up of 141 nonsurgical cases. Am. J. Cardiol.36, 131–135 (1975).
   PubMed Web of Science ®Google Scholar
• Taylor HA, Deumite NJ, Chaitman BR, Davis KB, Killip T, Rogers WJ. Asymptomatic left main coronary artery disease in the Coronary Artery Surgery Study (CASS) registry. Circulation79, 1171–1179 (1989).
   PubMed Web of Science ®Google Scholar
• Cohen MV, Cohn PF, Herman MV, Gorlin R. Diagnosis and prognosis of main left coronary artery obstruction. Circulation45, I57–I65 (1972).
   Web of Science ®Google Scholar
• Cohen MV, Gorlin R. Main left coronary artery disease. Clinical experience from 1964–1974. Circulation52, 275–285 (1975).
   PubMed Web of Science ®Google Scholar
• European Coronary Surgery Study Group. Coronary-artery bypass surgery in stable angina pectoris: survival at two years. Lancet1, 889–893 (1979).
   PubMedGoogle Scholar
• The Veterans Administration Coronary Artery Bypass Surgery Cooperative Study Group. Eleven-year survival in the Veterans Administration randomized trial of coronary bypass surgery for stable angina. N. Engl. J. Med.311, 1333–1339 (1984).
   PubMed Web of Science ®Google Scholar
• Takaro T, Peduzzi P, Detre KM et al. Survival in subgroups of patients with left main coronary artery disease. Veterans Administration Cooperative Study of Surgery for Coronary Arterial Occlusive Disease. Circulation66, 14–22 (1982).
   PubMed Web of Science ®Google Scholar
• Varnauskas E. Twelve-year follow-up of survival in the randomized European Coronary Surgery Study. N. Engl. J. Med.319, 332–337 (1988).
   PubMed Web of Science ®Google Scholar
• Yusuf S, Zucker D, Peduzzi P et al. Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration. Lancet344, 563–570 (1994).
   PubMed Web of Science ®Google Scholar
• Rodriguez A, Rodriguez AM, Baldi J et al. Coronary stenting versus coronary bypass surgery in patients with multiple vessel disease and significant proximal LAD stenosis: results from the ERACI II study. Heart89, 184–188 (2003).
   PubMed Web of Science ®Google Scholar
• Serruys PW, Ong AT, van Herwerden LA et al. Five-year outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease: the final analysis of the Arterial Revascularization Therapies Study (ARTS) randomized trial. J. Am. Coll. Cardiol.46, 575–581 (2005).
   PubMed Web of Science ®Google Scholar
• Silber S, Albertsson P, Aviles FF et al. Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. Eur. Heart J.26, 804–847 (2005).
   PubMed Web of Science ®Google Scholar
• Smith SC Jr, Feldman TE, Hirshfeld JW Jr et al. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (ACC/AHA/SCAI Writing Committee to update 2001 guidelines for percutaneous coronary intervention). Circulation113, e166–e286 (2006).
   PubMedGoogle Scholar
• Gruntzig AR, Senning A, Siegenthaler WE. Nonoperative dilatation of coronary-artery stenosis: percutaneous transluminal coronary angioplasty. N. Engl. J. Med.301, 61–68 (1979).
   PubMed Web of Science ®Google Scholar
• O’Keefe JH Jr, Hartzler GO, Rutherford BD et al. Left main coronary angioplasty: early and late results of 127 acute and elective procedures. Am. J. Cardiol.64, 144–47 (1989).
   PubMedGoogle Scholar
• Fischman DL, Leon MB, Baim DS et al. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators. N. Engl. J. Med.331, 496–501 (1994).
   PubMed Web of Science ®Google Scholar
• Serruys PW, de Jaegere P, Kiemeneij F et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. N. Engl. J. Med.331, 489–495 (1994).
   PubMed Web of Science ®Google Scholar
• Colombo A, Hall P, Nakamura S et al. Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance. Circulation91, 1676–1688 (1995).
   PubMed Web of Science ®Google Scholar
• Schomig A, Neumann FJ, Kastrati A et al. A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents. N. Engl. J. Med.334, 1084–1089 (1996).
   PubMed Web of Science ®Google Scholar
• Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. The EPIC Investigation. N. Engl. J. Med.330, 956–961 (1994).
   PubMed Web of Science ®Google Scholar
• Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization. The EPILOG Investigators. N. Engl. J. Med.336, 1689–1696 (1997).
   PubMed Web of Science ®Google Scholar
• Lincoff AM, Califf RM, Moliterno DJ et al. Complementary clinical benefits of coronary-artery stenting and blockade of platelet glycoprotein IIb/IIIa receptors. Evaluation of Platelet IIb/IIIa Inhibition in Stenting Investigators. N. Engl. J. Med.341, 319–327 (1999).
   PubMed Web of Science ®Google Scholar
• Topol EJ, Moliterno DJ, Herrmann HC et al. Comparison of two platelet glycoprotein IIb/IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with percutaneous coronary revascularization. N. Engl. J. Med.344, 1888–1894 (2001).
   PubMed Web of Science ®Google Scholar
• Kosuga K, Tamai H, Ueda K et al. Initial and long-term results of directional coronary atherectomy in unprotected left main coronary artery. Am. J. Cardiol.87, 838–843 (2001).
   PubMed Web of Science ®Google Scholar
• Ellis SG, Tamai H, Nobuyoshi M et al. Contemporary percutaneous treatment of unprotected left main coronary stenoses: initial results from a multicenter registry analysis 1994–1996. Circulation96, 3867–3872 (1997).
   PubMedGoogle Scholar
• Park SJ, Park SW, Hong MK et al. Stenting of unprotected left main coronary artery stenoses: immediate and late outcomes. J. Am. Coll. Cardiol.31, 37–42 (1998).
   PubMed Web of Science ®Google Scholar
• Silvestri M, Barragan P, Sainsous J et al. Unprotected left main coronary artery stenting: immediate and medium-term outcomes of 140 elective procedures. J. Am. Coll. Cardiol.35, 1543–1550 (2000).
   PubMed Web of Science ®Google Scholar
• Lefevre T, Louvard Y, Morice MC et al. Stenting of bifurcation lesions: classification, treatments, and results. Catheter. Cardiovasc. Interv.49, 274–283 (2000).
   PubMed Web of Science ®Google Scholar
• Black A, Cortina R, Bossi I, Choussat R, Fajadet J, Marco J. Unprotected left main coronary artery stenting: correlates of midterm survival and impact of patient selection. J. Am. Coll. Cardiol.37, 832–838 (2001).
   PubMedGoogle Scholar
• Takagi T, Stankovic G, Finci L et al. Results and long-term predictors of adverse clinical events after elective percutaneous interventions on unprotected left main coronary artery. Circulation106, 698–702 (2002).
   PubMed Web of Science ®Google Scholar
• Park SJ, Park SW, Hong MK et al. Long-term (three-year) outcomes after stenting of unprotected left main coronary artery stenosis in patients with normal left ventricular function. Am. J. Cardiol.91, 12–16 (2003).
   PubMed Web of Science ®Google Scholar
• Tan WA, Tamai H, Park SJ et al. Long-term clinical outcomes after unprotected left main trunk percutaneous revascularization in 279 patients. Circulation104, 1609–1614 (2001).
   PubMed Web of Science ®Google Scholar
• Morice MC, Serruys PW, Sousa JE et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N. Engl. J. Med.346, 1773–1780 (2002).
   PubMed Web of Science ®Google Scholar
• Stone GW, Ellis SG, Cox DA et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N. Engl. J. Med.350, 221–231 (2004).
   PubMed Web of Science ®Google Scholar
• de Lezo JS, Medina A, Pan M et al. Rapamycin-eluting stents for the treatment of unprotected left main coronary disease. Am. Heart J.148, 481–485 (2004).
   PubMed Web of Science ®Google Scholar
• Chieffo A, Stankovic G, Bonizzoni E et al. Early and mid-term results of drug-eluting stent implantation in unprotected left main. Circulation111, 791–795 (2005).
   PubMed Web of Science ®Google Scholar
• Valgimigli M, van Mieghem CA, Ong AT et al. Short- and long-term clinical outcome after drug-eluting stent implantation for the percutaneous treatment of left main coronary artery disease: insights from the Rapamycin-Eluting and Taxus Stent Evaluated At Rotterdam Cardiology Hospital registries (RESEARCH and T-SEARCH). Circulation111, 1383–1389 (2005).
   PubMed Web of Science ®Google Scholar
• Park SJ, Kim YH, Lee BK et al. Sirolimus-eluting stent implantation for unprotected left main coronary artery stenosis: comparison with bare metal stent implantation. J. Am. Coll. Cardiol.45, 351–356 (2005).
   PubMed Web of Science ®Google Scholar
• Price MJ, Cristea E, Sawhney N et al. Serial angiographic follow-up of sirolimus-eluting stents for unprotected left main coronary artery revascularization. J. Am. Coll. Cardiol.47, 871–877 (2006).
   PubMed Web of Science ®Google Scholar
• Valgimigli M, Malagutti P, Aoki J et al. Sirolimus-eluting versus paclitaxel-eluting stent implantation for the percutaneous treatment of left main coronary artery disease: a combined RESEARCH and T-SEARCH long-term analysis. J. Am. Coll. Cardiol.47, 507–514 (2006).
   PubMedGoogle Scholar
• Valgimigli M, Malagutti P, Rodriguez-Granillo GA et al. Distal left main coronary disease is a major predictor of outcome in patients undergoing percutaneous intervention in the drug-eluting stent era: an integrated clinical and angiographic analysis based on the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) and Taxus-Stent Evaluated At Rotterdam Cardiology Hospital (T-SEARCH) registries. J. Am. Coll. Cardiol.47, 1530–1537 (2006).
   PubMed Web of Science ®Google Scholar
• Colombo A, Stankovic G, Orlic D et al. Modified T-stenting technique with crushing for bifurcation lesions: immediate results and 30-day outcome. Catheter. Cardiovasc. Interv.60, 145–151 (2003).
   PubMed Web of Science ®Google Scholar
• Hoye A, Iakovou I, Ge L et al. Long-term outcomes after stenting of bifurcation lesions with the "crush" technique: predictors of an adverse outcome. J. Am. Coll. Cardiol.47, 1949–1958 (2006).
   PubMed Web of Science ®Google Scholar
• Kim YH, Park SW, Hong MK et al. Comparison of simple and complex stenting techniques in the treatment of unprotected left main coronary artery bifurcation stenosis. Am. J. Cardiol.97, 1597–1601 (2006).
   PubMed Web of Science ®Google Scholar
• Chieffo A, Morici N, Maisano F et al. Percutaneous treatment with drug-eluting stent implantation versus bypass surgery for unprotected left main stenosis: a single-center experience. Circulation113, 2542–2547 (2006).
   PubMed Web of Science ®Google Scholar
• Lee MS, Kapoor N, Jamal F et al. Comparison of coronary artery bypass surgery with percutaneous coronary intervention with drug-eluting stents for unprotected left main coronary artery disease. J. Am. Coll. Cardiol.47, 864–870 (2006).
   PubMed Web of Science ®Google Scholar
• Nashef SA, Roques F, Michel P, Gauducheau E, Lemeshow S, Salamon R. European System for Cardiac Operative Risk Evaluation (EuroSCORE). Eur. J. Cardiothorac. Surg.16, 9–13 (1999).
   PubMed Web of Science ®Google Scholar
• Kim YH, Ahn JM, Park DW et al. EuroSCORE as a predictor of death and myocardial infarction after unprotected left main coronary stenting. Am. J. Cardiol.98, 1567–1570 (2006).
   PubMed Web of Science ®Google Scholar
• Shuchman M. Trading restenosis for thrombosis? New questions about drug-eluting stents. N. Engl. J. Med.355, 1949–1952 (2006).
   PubMed Web of Science ®Google Scholar
• Virmani R, Guagliumi G, Farb A et al. Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious? Circulation109, 701–705 (2004).
   PubMed Web of Science ®Google Scholar
• Taggart DP, D’Amico R, Altman DG. Effect of arterial revascularisation on survival: a systematic review of studies comparing bilateral and single internal mammary arteries. Lancet358, 870–875 (2001).
   PubMed Web of Science ®Google Scholar
• Newman MF, Kirchner JL, Phillips-Bute B et al. Longitudinal assessment of neurocognitive function after coronary-artery bypass surgery. N. Engl. J. Med.344, 395–402 (2001).
   PubMed Web of Science ®Google Scholar
• Ong AT, Serruys PW, Mohr FW et al. The SYNergy between percutaneous coronary intervention with TAXus and cardiac surgery (SYNTAX) study: design, rationale, and run-in phase. Am. Heart J.151, 1194–1204 (2006).
   PubMed Web of Science ®Google Scholar
• Agostoni P, Valgimigli M, van Mieghem CA et al. Comparison of early outcome of percutaneous coronary intervention for unprotected left main coronary artery disease in the drug-eluting stent era with versus without intravascular ultrasonic guidance. Am. J. Cardiol.95, 644–647 (2005).
   PubMedGoogle Scholar
• Price MJ. Unprotected left main coronary intervention with drug-eluting stents. J. Interv. Cardiol.19, S21–S26 (2006).
   Google Scholar